Skip to main content
Log in

CEACAM5 is correlated with Angio/Lymphangiogenesis of Prostatic Lesions

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Objective

The aim of this study was to examine the expression patterns of CEACAM5 in prostatic non-neoplastic and neoplastic lesions and further investigate its relationship with tumor microvessel density(MVD) and lymphatic vessel density(LVD).

Methods

CEACAM5 expression was detected using immunohistochemical staining in a serial sections of the benign prostatic hyperplasia (BPH), prostate intraepithelial neoplasia (PIN) and prostate carcinoma (PCa) lesions. MVD and LVD were quantified in CEACAM5 positive areas by dual-labelling with CD34 and D2-40 respectively.

Results

Both PIN and PCa had significantly higher expression for CEACAM5 than BPH which has no positive expression for CEACAM5(P<0.05). In PIN and PCa, CEACAM5 staining showed different expression patterns in terms the of most of membranous staining for PIN, less membranous staining and more cytoplasmic staining for PCa. MVD results showed that PCa and PIN had more angiogenesis than BPH tissue. The value of MVD in PCa tissue was correlated with tumor Gleason grading (P<0.05). LVD results showed that neoplastic lesions had more lymphangiogenesis than non-neoplastic lesion.

Conclusion

CEACAM5 had different expression patterns in prostatic non-neoplastic and neoplastic lesions, and these various expression patterns may be correlated with tumor progression through promoting tumorous angiogenesis or lymphangiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J Biol Chem. 2000 Sep 1;275(35):26935–26943

    CAS  PubMed  Google Scholar 

  3. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 2000 Jul 1;60(13):3419–3424

    CAS  PubMed  Google Scholar 

  4. Ilantzis C, DeMarte L, Screaton RA, Stanners CP. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia. 2002 Mar–Apr;4(2):151–163

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Chan CH, Cook D, Stanners CP. Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice. Carcinogenesis. 2006 Sep;27(9):1909–1916

    Article  CAS  PubMed  Google Scholar 

  6. Chan CH, Camacho-Leal P, Stanners CP. Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family memberexpression in transgenic mice. PLoS One. 2007 Dec 26;2(12):e1353

    Article  PubMed Central  PubMed  Google Scholar 

  7. Hostetter RB, Campbell DE, Chi KF, Kerckhoff S, Cleary KR, Ullrich S, Thomas P, Jessup JM. Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma. Arch Surg. 1990 Mar;125(3):300–304

    Article  CAS  PubMed  Google Scholar 

  8. Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin Exp Metastasis. 1994 Jul;12(4):324–328

    Article  CAS  PubMed  Google Scholar 

  9. Zareba P, Zhang J, Yilmaz A, Trpkov K. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice. Histopathology. 2009 Oct;55(4):384–391

    Article  PubMed  Google Scholar 

  10. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992 Dec 16;84(24):1875–1887

    Article  CAS  PubMed  Google Scholar 

  11. Ferro M, Bruzzese D, Perdonà S, Mazzarella C, Marino A, Sorrentino A, Di Carlo A, Autorino R, Di Lorenzo G, Buonerba C, Altieri V, Mariano A, Macchia V, Terracciano D. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. Clin Chim Acta. 2012 Aug 16;413(15–16):1274–1278

    Article  CAS  PubMed  Google Scholar 

  12. Terracciano D, Bruzzese D, Ferro M, Mazzarella C, Di Lorenzo G, Altieri V, Mariano A, Macchia V, Di Carlo A. Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading. Prostate. 2012 Jan;72(1):100–107

    Article  CAS  PubMed  Google Scholar 

  13. Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EE. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg. 2005 Mar;241(3):491–496

    Article  PubMed  Google Scholar 

  14. Glinsky GV. Anti-adhesion cancer therapy. Cancer Metastasis Rev. 1998 Jun;17(2):177–185

    Article  CAS  PubMed  Google Scholar 

  15. Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene. 2002 Dec 12;21(57):8683–8695

    Article  CAS  PubMed  Google Scholar 

  16. Zhou H, Stanners CP, Fuks A. Specificity of anticarcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion. Cancer Res. 1993 Aug 15;53(16):3817–3822

    CAS  PubMed  Google Scholar 

  17. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res. 2004 Jun 1;64(11):3987–3993

    Article  CAS  PubMed  Google Scholar 

  18. Yoshioka T, Masuko T, Kotanagi H, Aizawa O, Saito Y, Nakazato H, Koyama K, Hashimoto Y. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res. 1998 Feb;89(2):177–185

    Article  CAS  PubMed  Google Scholar 

  19. Thomas P, Gangopadhyay A, Steele G Jr, Andrews C, Nakazato H, Oikawa S, Jessup JM. The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101. Cancer Lett. 1995 May 25;92(1):59–66

    Article  CAS  PubMed  Google Scholar 

  20. Charbonneau J, Stanners CP. Role of carbohydrate structures in CEA-mediated intercellular adhesion. Cell Adhes Commun. 1999;7(3):233–244

    Article  CAS  PubMed  Google Scholar 

  21. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as a intercellular adhesion molecule. Cell. 1989 Apr 21;57(2):327–334

    Article  CAS  PubMed  Google Scholar 

  22. Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen(NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun. 1989 Oct 16;164(1):39–45

    Article  CAS  PubMed  Google Scholar 

  23. Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012 Mar;61(3):480–487

    Article  PubMed  Google Scholar 

  24. Yamamura T, Tsukikawa S, Yamada K, Yamaguchi S. Morphologic analysis of microvessels in colorectal tumors with respect to the formation of liver metastases. J Surg Oncol. 2001 Dec;78(4):259–264

    Article  CAS  PubMed  Google Scholar 

  25. Yoshida Y, Kurokawa T, Fukuno N, Nishikawa Y, Kamitani N, Kotsuji F. Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma. Hum Pathol. 2000 Dec;31(12):1448–1454

    Article  CAS  PubMed  Google Scholar 

  26. Jebreel A, England J, Bedford K, Murphy J, Karsai L, Atkin S. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases. Int J Exp Pathol. 2007 Aug;88(4):271–217

    Article  PubMed Central  PubMed  Google Scholar 

  27. Garcia EA, Simões K, Wakamatsu A, Ressio RA, Alves VA, Longatto-Filho A, Camargo RS. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions. Endocr Pathol. 2010 Jun;21(2):101–107

    Article  CAS  PubMed  Google Scholar 

  28. Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-Beltran A, Zhang S, Badve S, Baldridge LA, Montironi R. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol. 2008 Apr;39(4):610–615

    Article  PubMed  Google Scholar 

  29. Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol. 2004 Jul;172(1):103–107

    Article  CAS  PubMed  Google Scholar 

  30. Gimeno-García AZ, Elwassief AE, Paquin SC, Sahai AV. Endoscopic ultrasound-guided fine needle aspiration cytology and biopsy in the evaluation of lymphoma. Endoscopic Ultrasound. 2012. 2012 May;1(1):17–22

    Google Scholar 

  31. Eckardt J, Olsen KE, Petersen H. Metastasis in the subcarinal lymph node with unknown primary tumor. Thoracic Cancer. 2011 May;2(2):69–70

    Article  Google Scholar 

  32. Liang Y, Fu D, Hu G. Metadherin: An emerging key regulator of the malignant progression of multiple cancers. Thoracic Cancer 2011 Nov;2(4):143–148

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shengtian Zhao.

About this article

Cite this article

Yan, Jk., Wang, Yz., Tian, C. et al. CEACAM5 is correlated with Angio/Lymphangiogenesis of Prostatic Lesions. cent.eur.j.med 9, 264–271 (2014). https://doi.org/10.2478/s11536-013-0153-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0153-x

Keywords

Navigation